Lactulose lowers arterial ammonia in hepatic failure
Ratnaike, R.N.; O'Halloran, M.W.; Hislop, I.G.
American Journal of Gastroenterology 58(6): 626-632
1972
ISSN/ISBN: 0002-9270 PMID: 4648406 Document Number: 46974
Document emailed within 1 workday
Related Documents
Watanabe, A.; Tsuchida, T.; Kuwabara, Y. 1997: Two models of acute hepatic failure with extensive hepatic necrosis and blood ammonia elevation in small animals Journal of Medicine 28(1-2): 45-48Hasan, S.; Datta, S.; Bhattacherjee, S.; Banik, S.; Saha, S.; Bandyopadhyay, D. 2018: A Randomized Controlled Trial Comparing the Efficacy of a Combination of Rifaximin and Lactulose with Lactulose only in the Treatment of Overt Hepatic Encephalopathy Journal of the Association of Physicians of India 66(1): 32-36
Snady, H.; Lieber, C.S. 1988: Venous, arterial, and arterialized-venous blood ammonia levels and their relationship to hepatic encephalopathy after propranolol American Journal of Gastroenterology 83(3): 249-255
1976: Lactulose for hepatic encephalopathy Medical Letter on Drugs and Therapeutics 18(1): 3-4
Fujimoto, T.; Yoshimatsu, K.; Yokomizo, H.; Umehara, A.; Watanabe, K.; Otani, T.; Matsumoto, A.; Osawa, G.; Itagaki, H.; Ogawa, K. 2007: Extra- and intra-hepatic metastasis successfully treated with alternative chemotherapy with hepatic arterial infusion and systemic intravenous infusion after responding to hepatic metastasis from colon cancer by hepatic arterial infusion--a case report Gan to Kagaku Ryoho. Cancer and ChemoTherapy 34(12): 1976-1978
Fung, W.P.; Khoo, O.T. 1971: Lactulose in the treatment of acute and chronic hepatic encephalopathy Singapore Medical Journal 12(3): 176-180
Schumann, C. 1992: The lactulose challenge. Part 1. on the cholesterol lowering effect of lactulose Zeitschrift für Arztliche Fortbildung 86(18): 901-904
Riggio, O.; Balducci, G.; Ariosto, F.; Merli, M.; Tremiterra, S.; Ziparo, V.; Capocaccia, L. 1990: Lactitol in the treatment of chronic hepatic encephalopathy--a randomized cross-over comparison with lactulose Hepato-Gastroenterology 37(5): 524-527
Vendemiale, G.; Palasciano, G.; Cirelli, F.; Altamura, M.; De Vincentiis, A.; Altomare, E. 1992: Crystalline lactulose in the therapy of hepatic cirrhosis. Evaluation of clinical and immunological parameters. Preliminary results Arzneimittel-Forschung 42(7): 969-972
Blanc, P.; Daurès, J.P.; Liautard, J.; Buttigieg, R.; Desprez, D.; Pageaux, G.; Allaz, J.L.; Parelon, G.; Larrey, D.; Michel, H. 1994: Lactulose-neomycin combination versus placebo in the treatment of acute hepatic encephalopathy. Results of a randomized controlled trial Gastroenterologie Clinique et Biologique 18(12): 1063-1068
Watanabe, M.; Tsuchiya, M.; Takita, W.; Otsuka, Y.; Tamura, A.; Yamazaki, K.; Koshino, H.; Kurihara, A.; Kaneko, H.; Teramoto, T. 2006: Case report of a liver metastasis from rectal cancer achieving complete response (CR) by a combination of intra-hepatic arterial infusion of irinotecan (CPT-11) with degradable starch microspheres (DSM) and weekly high-dose intra-hepatic arterial chemotherapy with 5-FU Gan to Kagaku Ryoho. Cancer and ChemoTherapy 33(10): 1485-1488
Chauveau, P.; Chadefaux, B.; Coudé, M.; Aupetit, J.; Kamoun, P.; Jungers, P. 1996: Long-term folic acid (but not pyridoxine) supplementation lowers elevated plasma homocysteine level in chronic renal failure Mineral and Electrolyte Metabolism 22(1-3): 106-109
Felicilda-Reynaldo, R.F.D. 2012: Ammonia abolishers: antibiotics for hepatic encephalopathy Medsurg Nursing: Official Journal of the Academy of Medical-Surgical Nurses 21(3): 173-175; Quiz 176
Shibata, T.; Morita, T.; Okuyama, M.; Kitada, M.; Shimano, T.; Ishida, T. 2002: Comparison of percutaneous microwave coagulation area under interruption of hepatic arterial blood flow with that under hepatic arterial and venous blood flow for hepatocellular carcinoma Gan to Kagaku Ryoho. Cancer and ChemoTherapy 29(12): 2146-2148
Niwa, T.; Nomura, T.; Sugiyama, S.; Miyazaki, T.; Tsukushi, S.; Tsutsui, S. 1997: The protein metabolite hypothesis, a model for the progression of renal failure: an oral adsorbent lowers indoxyl sulfate levels in undialyzed uremic patients Kidney International. Supplement 62: S23-S28
Helewski, K.; Kowalczyk-Ziomek, G.; Konecki, J. 2003: Ammonia and GABA-ergic neurotransmission in pathogenesis of hepatic encephalopathy Wiadomosci Lekarskie 56(11-12): 560-563
Campollo, O.; MacGillivray, B.B.; McIntyre, N. 1992: Association of plasma ammonia and GABA levels and the degree of hepatic encephalopathy Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion 44(4): 483-490
Kamiyama, Y.; Takeda, H.; Ohshita, M.; Nambu, H.; Yamaoka, Y. 1977: Hepatic metabolic changes following energy deprivation by ammonia in patients and rabbits with jaundice Surgery Gynecology and Obstetrics 145(1): 33-40
Osawa, G.; Yoshimatsu, K.; Yokomizo, H.; Otani, T.; Yano, Y.; Itagaki, H.; Matsumoto, A.; Fujimoto, T.; Umehara, A.; Ogawa, K. 2010: A case of multiple lung and liver metastases from colon cancer treated with clinical benefit by hepatic arterial infusion chemotherapy plus cetuximab mono-therapy after standard chemotherapy failure Gan to Kagaku Ryoho. Cancer and ChemoTherapy 37(12): 2526-2528
Demedts, M.; Pillen, E.; De Groote, J.; Van de Woestijne, K.P. 1973: Hepatic encephalopathy: comparative study of EEG abnormalities, neuropsychic disturbances and blood ammonia Acta Neurologica Belgica 73(5): 281-288